Literature DB >> 8846486

Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies.

C M Silveira1, V M Cáceres, M G Dutra, J Lopes-Camelo, E E Castilla.   

Abstract

Reported are the results of the Latin American Collaborative Study of Congenital Malformations (ECLAMC), a hospital-based case-control study of 34,293 malformed and 34,477 matched nonmalformed newborn controls. No statistical differences were found between the malformed and control groups, exposed or not exposed to tetanus toxoid.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8846486      PMCID： PMC2486812     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  4 in total

1.  Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy.

Authors:  F D SCHOFIELD; V M TUCKER; G R WESTBROOK
Journal:  Br Med J       Date:  1961-09-23

2.  The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial.

Authors:  K W Newell; A Dueñas Lehmann; D R LeBlanc; N Garces Osorio
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

3.  [Socioeconomic level as an error-generating variable in studies of ethnicity].

Authors:  A D Passos; J C Cardoso; J E Paz; E E Castilla
Journal:  Rev Saude Publica       Date:  1978-06       Impact factor: 2.106

4.  Prevalence rates of microtia in South America.

Authors:  E E Castilla; I M Orioli
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196
  4 in total
  12 in total

Review 1.  Tetanus.

Authors:  J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 2.  Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review.

Authors:  Marinos C Makris; Konstantinos A Polyzos; Michael N Mavros; Stavros Athanasiou; Petros I Rafailidis; Matthew E Falagas
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

3.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

4.  Vaccination during pregnancy.

Authors:  Pina Bozzo; Andrea Narducci; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

Review 5.  Vaccines for women for preventing neonatal tetanus.

Authors:  Vittorio Demicheli; Antonella Barale; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2015-07-06

Review 6.  Human teratogens update 2011: can we ensure safety during pregnancy?

Authors:  Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-13

Review 7.  Immunization During Pregnancy: Impact on the Infant.

Authors:  Kirsten P Perrett; Terry M Nolan
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

8.  Vaccination during pregnancy: Today's need in India.

Authors:  Ramesh Verma; Pardeep Khanna; Mukesh Dhankar
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

9.  Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Malini DeSilva; Flor M Munoz; Mark Mcmillan; Alison Tse Kawai; Helen Marshall; Kristine K Macartney; Jyoti Joshi; Martina Oneko; Annette Elliott Rose; Helen Dolk; Francesco Trotta; Hans Spiegel; Sylvie Tomczyk; Anju Shrestha; Sonali Kochhar; Elyse O Kharbanda
Journal:  Vaccine       Date:  2016-07-18       Impact factor: 3.641

Review 10.  A systematic review of adverse events following immunization during pregnancy and the newborn period.

Authors:  T Roice Fulton; Divya Narayanan; Jan Bonhoeffer; Justin R Ortiz; Philipp Lambach; Saad B Omer
Journal:  Vaccine       Date:  2015-09-26       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.